The FDA is planning on imposing severe restrictions on the sale of e-cigarette products as soon as next week; marijuana was a hit with voters in the midterm election; HHS is recommending a ban on the chemicals in kratom that would make the herb as illegal as heroin or LSD.
The FDA is planning on imposing severe restrictions on the sale of e-cigarette products as soon as next week, The Washington Post reported. The ban would come as public health experts are alarmed by a huge increase in vaping among minors. The agency will also impose such rules as age-verification requirements for online sales, and it is expected to propose banning menthol in regular cigarettes.
Marijuana was a hit with voters in the midterm elections, The Hill reported. In Missouri and Utah, voters approved medical cannabis, and in Michigan, voters legalized the adult use, cultivation, and retail marketing of marijuana. In 4 states—Connecticut, Michigan, Minnesota, and Illinois—voters elected governors who openly campaigned on a platform that included legalizing adult marijuana use. In California and Colorado, voters elected governors who have spearheaded legalization reform efforts. In Maine and in New Mexico, 2 antimarijuana governors were replaced by candidates seeking cannabis reforms.
HHS is recommending a ban on the chemicals in kratom that would make the popular herbal supplement as illegal as heroin or LSD by classifying them as Schedule I substances, according to STAT News. Some scientists are worried that a ban would stifle research on chemicals that could be developed into opioid alternatives and said that banning kratom would harm people who are currently using the substance.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More